175 related articles for article (PubMed ID: 7055874)
1. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
[TBL] [Abstract][Full Text] [Related]
2. Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
Magorien RD; Unverferth DV; Brown GP; Leier CV
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):499-505. PubMed ID: 6826960
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
4. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
5. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
[TBL] [Abstract][Full Text] [Related]
6. Vasodilators in heart failure secondary to coronary artery disease.
Parmley WW; Rouleau JL; Chatterjee K
Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
[TBL] [Abstract][Full Text] [Related]
7. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
8. Comparison of isradipine with nitroprusside for control of blood pressure following myocardial revascularization: effects on hemodynamics, cardiac metabolism, and coronary blood flow.
Underwood SM; Davies SW; Feneck RO; Lunnon MW; Walesby RK
J Cardiothorac Vasc Anesth; 1991 Aug; 5(4):348-56. PubMed ID: 1831394
[TBL] [Abstract][Full Text] [Related]
9. Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment.
Rubin SA; Brown HV; Swan HJ
Circulation; 1982 Jul; 66(1):143-8. PubMed ID: 7083500
[TBL] [Abstract][Full Text] [Related]
10. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
Kittleson MD; Johnson LE; Oliver NB
J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
[TBL] [Abstract][Full Text] [Related]
12. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure.
Magorien RD; Leier CV; Kolibash AJ; Barbush TJ; Unverferth DV
Circulation; 1984 Nov; 70(5):884-90. PubMed ID: 6488501
[TBL] [Abstract][Full Text] [Related]
15. Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
Am J Cardiol; 1981 Nov; 48(5):939-46. PubMed ID: 7304442
[TBL] [Abstract][Full Text] [Related]
16. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
18. Systemic and coronary hemodynamic and neurohumoral effects of levodopa in chronic congestive heart failure.
De Marco T; Daly PA; Chatterjee K
Am J Cardiol; 1988 Dec; 62(17):1228-33. PubMed ID: 2904216
[TBL] [Abstract][Full Text] [Related]
19. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
20. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
